Model-based evaluation of the cost effectiveness of 3 versus 6 months’ adjuvant chemotherapy in high-risk stage II colon cancer patients

BACKGROUND: Our aim was to evaluate the cost effectiveness of 3 months’ adjuvant chemotherapy versus 6 months in high-risk (T4 stage + microsatellite stable) stage II colon cancer (CC) patients. METHODS: Using the validated PATTERN Markov cohort model, which simulates the disease progression of stag...

Descripción completa

Detalles Bibliográficos
Autores principales: Jongeneel, Gabrielle, Greuter, Marjolein J. E., van Erning, Felice N., Koopman, Miriam, Vink, Geraldine R., Punt, Cornelis J. A., Coupé, Veerle M. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502861/
https://www.ncbi.nlm.nih.gov/pubmed/32994804
http://dx.doi.org/10.1177/1756284820954114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502861/
https://www.ncbi.nlm.nih.gov/pubmed/32994804
http://dx.doi.org/10.1177/1756284820954114

Ejemplares similares